10x Genomics Ownership | Who Owns 10x Genomics?

Overview Forecast RevenueFinancials Chart Transcripts

10x Genomics Ownership Summary

10x Genomics is owned by 61.80% institutional investors, 1.81% insiders, and 36.40% retail investors. Vanguard group is the largest institutional shareholder, holding 10.37% of TXG shares. ARK Disruptive Innovation Full Composite is the top mutual fund, with 6.02% of its assets in 10x Genomics shares.

TXG Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	10x Genomics	61.80%	1.81%	36.40%
Sector	Healthcare Stocks	232.01%	10.74%	-142.75%
Industry	Healthcare Information Services Stocks	33.19%	12.66%	54.15%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	13.02M	10.37%	$212.32M
Ark investment management	12.67M	10.09%	$206.60M
Blackrock funding, inc. /de	10.01M	7.98%	$163.34M
Fmr	8.46M	6.83%	$98.87M
Blackrock	6.39M	5.35%	$124.34M
Sumitomo mitsui trust	5.49M	4.38%	$89.58M
Nikko asset management americas	5.49M	4.37%	$89.42M
Wellington management group llp	4.29M	3.46%	$50.10M
Quantinno capital management lp	3.49M	2.82%	$40.83M
Morgan stanley	3.20M	2.52%	$52.14M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Venrock management vi	2.11M	100.00%	$40.98M
Tao capital management lp	210.86K	1.86%	$2.46M
Ark investment management	12.67M	1.37%	$206.60M
Sands capital ventures	481.77K	1.23%	$5.63M
Exome asset management	163.66K	1.16%	$1.91M
Nikko asset management americas	5.49M	1.03%	$89.42M
Iq eq fund management (ireland)	632.08K	0.71%	$10.31M
Nano cap new millennium growth fund l p	30.00K	0.42%	$489.30M
Financial consulate	156.46K	0.35%	$2.55M
Fortis group advisors	82.92K	0.28%	$1.67M

Top Buyers

Holder	Shares	% Assets	Change
Wellington management group llp	4.29M	0.01%	2.39M
Quantinno capital management lp	3.49M	0.11%	1.26M
Royal bank of canada	1.43M	0.00%	1.22M
D. e. shaw	1.22M	0.01%	1.22M
Ark investment management	12.67M	1.37%	779.97K

Top Sellers

Holder	Shares	% Assets	Change
Generation investment management llp	-	-	-2.88M
Brown capital management	-	-	-1.84M
Point72 asset management	-	-	-1.23M
Blue water life science advisors, lp	-	-	-1.10M
Camber capital management lp	-	-	-1.00M

New Positions

Holder	Shares	% Assets	Change	Value
D. e. shaw	1.22M	0.01%	1.22M	$17.50M
Simplify asset management	485.98K	0.13%	485.98K	$7.93M
Exoduspoint capital management, lp	251.73K	0.03%	251.73K	$2.94M
Centerbook partners lp	230.77K	0.18%	230.77K	$3.76M
Ossiam	229.30K	0.03%	229.30K	$2.68M

Sold Out

Holder	Change
Key financial	-2.00
Strategic advocates	-2.00
Concourse financial group securities	-3.00
Mather group, llc.	-4.00
Northwest investment counselors	-6.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	225	-30.12%	77,554,892	-36.98%	61	0.62%	120	-29.82%	63	-27.59%
Sep 30, 2025	296	1.72%	116,328,619	2.84%	93	1.13%	157	-14.21%	83	20.29%
Jun 30, 2025	299	7.94%	122,334,806	8.44%	98	1.17%	185	19.35%	73	-1.35%
Mar 31, 2025	277	-0.72%	113,747,605	8.46%	92	1.22%	155	3.33%	74	-20.43%
Dec 31, 2024	264	-1.86%	102,915,574	-1.38%	85	1.14%	143	-10.06%	85	19.72%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
ARK Disruptive Innovation Full Composite	7.69M	6.02%	438.50K
ARK Innovation ETF	7.22M	5.65%	109.65K
Vanguard Total Stock Mkt Idx Inv	3.47M	2.72%	10.32K
Vanguard US Total Market Shares ETF	3.24M	2.65%	268.60K
Nikko AM ARK Disruptive Innovation A USD	3.14M	2.55%	126.16K
ARK Genomic Revolution ETF	3.25M	2.54%	-
ARK Genomic Revolution	3.15M	2.47%	168.39K
Amova ARK Disruptive Innovation A USD	3.01M	2.35%	-75.20K
iShares Russell 2000 ETF	2.66M	2.08%	2.66M
Nikko AM ARK Pstv Chg Innovt P JPY Acc	2.50M	2.03%	340.68K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 02, 2026	Saxonov Serge	Chief Executive Officer	Sell	$323.99K
Mar 02, 2026	Saxonov Serge	Chief Executive Officer	Sell	$43.11K
Feb 25, 2026	Teichmann Sarah A.	-	Sell	$147.11K
Feb 23, 2026	Saxonov Serge	Chief Executive Officer	Sell	$178.93K
Feb 23, 2026	Taich Adam	Chief Financial Officer	Sell	$166.59K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	6
2025 Q4	-	3
2025 Q3	-	3
2025 Q2	-	3
2025 Q1	1	3

TXG Ownership FAQ

Who Owns 10x Genomics?

10x Genomics shareholders are primarily institutional investors at 61.80%, followed by 1.81% insiders and 36.39% retail investors. The average institutional ownership in 10x Genomics's industry, Healthcare Information Services Stocks , is 33.19%, which 10x Genomics exceeds.

Who owns the most shares of 10x Genomics?

10x Genomics’s largest shareholders are Vanguard group (13.02M shares, 10.37%), Ark investment management (12.67M shares, 10.09%), and Blackrock funding, inc. /de (10.01M shares, 7.98%). Together, they hold 28.45% of 10x Genomics’s total shares outstanding.

Does Blackrock own 10x Genomics?

Yes, BlackRock owns 5.35% of 10x Genomics, totaling 6.39M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 124.34M$. In the last quarter, BlackRock increased its holdings by 385.01K shares, a 6.41% change.

Who is 10x Genomics’s biggest shareholder by percentage of total assets invested?

Venrock management vi is 10x Genomics’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 2.11M 10x Genomics shares, valued at 40.98M$.

Who is the top mutual fund holder of 10x Genomics shares?

ARK Disruptive Innovation Full Composite is the top mutual fund holder of 10x Genomics shares, with 6.02% of its total shares outstanding invested in 7.69M 10x Genomics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools